Resultados de la búsqueda 351-360 of 8878 for Lithium toxicity

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...

2. Radiología - Ensayos clínicos - Mayo Clinic

   The main questions the study aims to answer in Phase/Part 1 of the trial are: * Is \[Ac225\]RTX-2358 tolerable or does it cause toxicities (medical problems) in ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

4. Hematología - Ensayos clínicos - Mayo Clinic

   Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

7. Hematología - Ensayos clínicos - Mayo Clinic

   Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...